NextCure, Inc. has announced that it has dosed its first patient in a Phase 1 clinical trial for LNCB74, an antibody-drug conjugate targeting ... by GlobeNewswire. The model used to summarize ...
The theory behind antibody drug conjugates (ADCs ... and R&D to commercial operating model. It is on industry leaders to continue to push the boundaries of science and commercialise appropriately.
Bispecific antibodies (BsAbs) are a major advancement in therapeutic oncology and hematology, capable of simultaneously engaging two distinct targets. This ...
Roche has licensed an antibody-drug conjugate (ADC) designed to treat advanced small-cell lung cancer from China-based Innovent Biologics for $80 million up front and up to $1 billion in milestone ...
Roche has licensed an antibody-drug conjugate (ADC) designed to treat advanced small-cell lung cancer from China-based Innovent Biologics for $80 million up front and up to $1 billion in milestone ...
Co., Ltd. The partnership will leverage MediLink's TMALIN antibody-drug conjugate (ADC) platform to develop a novel LRRC15 ADC, known as ZL-6201, which includes an antibody discovered by Zai Lab.
With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.
Novel CD37 antibody-drug conjugate shows promise in targeting the Achilles’ heel of acute myeloid leukemia cells.
The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with ...
In 2021, five out of the top 10 selling drugs were mAbs and this trend ... a structure-based approach, where their model is trained on millions of Antibody-Antigen pairs in order to identify ...
In a recent article in the journal Antioxidants, researchers in Germany investigated whether cardiovascular drugs such as alpha-blockers and beta-blockers can protect against the complications ...
Most of the 35,000 online pharmacies around the world are operating illegally and could be selling dangerous or ineffective drugs, according to the U.S. Trade Representative's annual "notorious ...